Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/6/26 19:30 | 2/4/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Piskel Kyle | WA | O | CFO | 3 | S.d | -3,292 | 19.45 | 0 | -169 | 217 | D | |||||||||||||||
2/4/26 19:48 | 2/2/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Robins Harlan S | WA | O | Chief Sc | 3 | S.m | -1,636 | 18.18 | 0 | -90 | 1,232 | D | |||||||||||||||
2/4/26 19:37 | 2/2/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Robins Chad M | WA | DO | CEO,CB | 3 | S.m | -7,324 | 17.83 | 0 | -411 | 2,709 | D | |||||||||||||||
1/14/26 19:42 | 1/12/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Lo Francis | WA | O | Chief Pe | 5 | S.d | -3,388 | 16.50 | 0 | -205 | 318 | D | |||||||||||||||
12/12/25 19:11 | 12/10/25 | ADPT | Health | BioPrd | Biological Products, (No Diag | Hershberg Robert | WA | D | 1 | S | -367 | 16.00 | 0 | -23 | 47 | D | ||||||||||||||||
12/8/25 20:00 | 12/4/25 | ADPT | Health | BioPrd | Biological Products, (No Diag | Benzeno Sharon | WA | O | Chief Co | 2 | S.dm | -10,356 | 16.73 | 0 | -619 | 297 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |